Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome

被引:7
|
作者
Hashimoto, Miki [1 ]
Itonaga, Hidehiro [2 ]
Nannya, Yasuhito [3 ]
Taniguchi, Hirokazu [4 ]
Fukuda, Yuichi [5 ]
Furumoto, Takafumi [6 ]
Fujioka, Machiko [1 ,7 ]
Kasai, Sachie [1 ]
Taguchi, Masataka [7 ]
Taniguchi, Hiroaki [6 ]
Sato, Shinya [7 ]
Sawayama, Yasushi [7 ]
Atogami, Sunao [8 ]
Iwasaki, Keisuke [9 ]
Hata, Tomoko [2 ]
Soda, Hiroshi [5 ]
Moriuchi, Yukiyoshi [6 ]
Nakata, Koh [10 ]
Ogawa, Seishi [3 ]
Miyazaki, Yasushi [1 ,2 ,7 ]
机构
[1] Nagasaki Univ, Dept Hematol, Grad Sch Biomed Sci, Nagasaki, Japan
[2] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Atom Bomb Dis & Hibakusha Med Unit, Nagasaki, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan
[4] Nagasaki Univ, Dept Resp Med, Grad Sch Biomed Sci, Nagasaki, Japan
[5] Sasebo City Gen Hosp, Dept Resp Med, Nagasaki, Japan
[6] Sasebo City Gen Hosp, Dept Hematol, Nagasaki, Japan
[7] Nagasaki Univ Hosp, Dept Hematol, Nagasaki, Japan
[8] Sasebo City Gen Hosp, Dept Clin Lab, Nagasaki, Japan
[9] Sasebo City Gen Hosp, Dept Pathol, Nagasaki, Japan
[10] Niigata Univ Med & Dent Hosp, Biosci Med Res Ctr, Niigata, Japan
基金
日本学术振兴会;
关键词
myelodysplastic syndromes; secondary pulmonary alveolar proteinosis; azacitidine; umbilical cord blood transplantation; PROGNOSTIC SCORING SYSTEM; CELL TRANSPLANTATION; DNA METHYLATION; DISEASE; NEOPLASMS; SURVIVAL; REGIMENS;
D O I
10.2169/internalmedicine.3770-19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Secondary pulmonary alveolar proteinosis (sPAP) is a complication of myelodysplastic syndrome (MDS). A 60-year-old woman was diagnosed with MDS with excess blasts-1. Fifty-four months after the initial diagnosis, treatment with azacitidine was initiated. Seventy-three months after the diagnosis, a bone marrow examination revealed increased myeloblasts, at which time computed tomography showed diffuse ground-glass opacities and interlobular septal thickening in the bilateral lower lung fields. A lung biopsy revealed the presence of PAP; therefore, the clinical diagnosis of MDS/sPAP was confirmed. Careful attention should be paid to the development of sPAP in MDS patients with pulmonary lesions during azacitidine treatment.
引用
收藏
页码:1081 / 1086
页数:6
相关论文
共 50 条
  • [1] Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome
    XIE Lixin ZHAO Tiemei WANG Qiaoyun CHEN Liangan LI Aimin WANG Dianjun QI Fei LIU Youning Department of Respiratory Medicine Department of Pathology Chinese PLA General HospitalBeijing China
    Chinese Medical Journal, 2007, 120 (12) : 1114 - 1116
  • [2] Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome
    XIE Li-xin ZHAO Tie-mei WANG Qiao-yun CHEN Liang-an LI Ai-min WANG Dian-jun QI Fei LIU You-ning Department of Respiratory Medicine Department of Pathology Chinese PLA General Hospital
    中华医学杂志(英文版), 2007, (12) : 1114 - 1116
  • [3] Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome
    Xie, Li-xin
    Zhao, Tie-mei
    Wang, Qiao-yun
    Chen, Liang-an
    Li, Ai-min
    Wang, Dian-jun
    Qi, Fei
    Liu, You-ning
    CHINESE MEDICAL JOURNAL, 2007, 120 (12) : 1114 - 1116
  • [4] Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome
    Ohnishi, T
    Yamada, G
    Shijubo, N
    Takagi-Takahashi, Y
    Itoh, T
    Takahashi, H
    Satoh, M
    Koba, H
    Nakata, K
    Abe, S
    INTERNAL MEDICINE, 2003, 42 (02) : 187 - 190
  • [5] A case of secondary pulmonary alveolar proteinosis, but prior to myelodysplastic syndrome
    Zhao, Yunfeng
    Xiong, Wei
    Wu, Xueling
    RESPIROLOGY CASE REPORTS, 2013, 1 (02): : 58 - 61
  • [6] Knowledge of Secondary Pulmonary Alveolar Proteinosis Complicated with Myelodysplastic Syndrome
    Ishii, Haruyuki
    INTERNAL MEDICINE, 2020, 59 (08) : 1019 - 1020
  • [7] Cytogenetic Features in Secondary Pulmonary Alveolar Proteinosis Complicated with Myelodysplastic Syndrome
    Ishii, H.
    Tazawa, R.
    Kitamura, N.
    Handa, T.
    Inoue, Y.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Clinical Features Of Secondary Pulmonary Alveolar ProteINOSis Complicated With Myelodysplastic Syndrome In Japan
    Ishii, H.
    Nakata, K.
    Tazawa, R.
    Goto, H.
    Inoue, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [9] CLINICAL CHARACTERISTICS OF SECONDARY PULMONARY ALVEOLAR PROTEINOSIS COMPLICATED WITH MYELODYSPLASTIC SYNDROME IN JAPAN
    Ishii, Haruyuki
    Nakata, Koh
    Tazawa, Ryushi
    Inoeu, Yoshikazu
    RESPIROLOGY, 2013, 18 : 38 - 38
  • [10] Possible Association of Trisomy 8 with Secondary Pulmonary Alveolar Proteinosis in Myelodysplastic Syndrome
    Nishida, Aya
    Miyamoto, Atsushi
    Yamamaoto, Hisashi
    Uchida, Naoyuki
    Izutsu, Koji
    Wake, Atsushi
    Ohta, Yasunori
    Fujii, Takeshi
    Araoka, Hideki
    Taniguchi, Shuichi
    Kishi, Kazuma
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (02) : 279 - 280